Researcher
Jacques De Grève
- Keywords:Medicine
- Disciplines:Cancer therapy, Cancer biology, Cancer prevention
Affiliations
- Medical Genetics (Department)
Member
From1 May 2019 → Today - Laboratory of Molecular and Medical Oncology (Research group)
Member
From1 Jan 2010 → Today - Clinical sciences (Department)
Member
From27 May 2019 → 30 Sep 2019 - Clinical sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2022 - Medical Oncology (Department)
Member
From1 Jul 2012 → 30 Apr 2019 - Medical Oncology (Department)
Member
From1 Jun 2010 → 31 Dec 2011 - Internal Medicine Specializations (Department)
Member
From25 Apr 2005 → 31 Dec 2013 - Medical Imaging and Physical Sciences (Department)
Member
From1 Jan 1999 → 24 Apr 2005
Projects
1 - 6 of 6
- Interdisciplinary Network in Fundamental and Medical Research on Lung and Pancreatic Cancer [NITROGEN]From1 Jul 2021 → TodayFunding: BOF - projects
- SRP-Groeifinanciering: Molecular Portrait of Pancreatic Tumours: Veni, vidi, viciFrom1 Mar 2019 → TodayFunding: University - Project driven research
- Interdisciplinary Network for Fundamental and Medical Research on Lung cancerFrom1 Jul 2016 → 30 Jun 2021Funding: University - Project driven research
- FWO-SB-beurs: Innovation through Combination: Identification of a novel combination therapy for improved treatment of EGFRFrom1 Jan 2016 → 31 Dec 2019Funding: FWO fellowships
- BruBreast: Development of diagnostic and therapeutic tools for the optimal management of the individual cancer patient.From1 Jun 2008 → 31 May 2011Funding: Brussels Capital Region
- Critical mutations and signals in breast cancer cells and their stromal environment.From1 Jan 2008 → 31 Dec 2009Funding: FWO research project
Publications
1 - 10 of 141
- Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia(2023)
Authors: Robert J Kreitman, Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne-Sophie Michallet, Zev A Wainberg, Alexander Stein, Sascha Dietrich, Maja J A de Jonge, et al.
Pages: 996-1006 - Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells(2023)
Authors: Mathias Elsocht, Philippe Giron, Jacques De Grève, Steven Ballet
- PRECISION(2022)
Authors: J Thouvenin, C Van Marcke, Lore Decoster, Gordana Raicevic, Kevin Punie, M. Vandenbulcke, R A Salgado, Els Van Valckenborgh, B Maes, Sofie Joris, et al.
- The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer(2022)
Authors: Carolien Eggermont, Philippe Giron, Amir Noeparast, Hugo Vandenplas, Pedro Aza-Blanc, Gustavo J Gutierrez, Jacques De Grève
- Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer(2022)
Authors: Sofie Joris, Christel Fontaine, Lore Decoster, Jacques Vanderauwera, Kris Thielemans, Wim Waelput, Jacques De Grève
Pages: 1433-1437 - Choroidal and Choriocapillaris Morphology in Pan-FGFR Inhibitor-Associated Retinopathy: A Case Report(2022)
Authors: Giuseppe Fasolino, Pieter Nelis, Marcel Ten Tusscher, Laura Moschetta, Jacques De Grève, Pierre Lefesvre
Pages: 1-7 - Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR)(2022)
Authors: Patrick Y Wen, Alexander Stein, Martin J van den Bent, Jacques De Grève, Antje Wick, Filip Y F L de Vos, Nikolas von Bubnoff, Myra E van Linde, Albert Lai, Gerald W Prager, et al.
Pages: 53-64 - Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth(2021)
Authors: Eva Reijmen, Sven de Mey, Helena Van Damme, Kirsten De Ridder, Thierry Gevaert, Emmy De Blay, Luc Bouwens, Christine Collen, Lore Decoster, Marijke De Couck, et al.
- Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication(2021)
Authors: D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, M. Campone, I Bondarenko, Z Nowecki, H Errihani, S Paluch-Shimon, et al.
Pages: 1245-1255 - Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors(2021)
Authors: Eva Reijmen, Sven de Mey, Wout De Mey, Thierry Gevaert, Kirsten De Ridder, Hanne Locy, Sandrina Martens, Emmy De Blay, Luc Bouwens, Pieterjan Debie, et al.
Pages: 272-283
Linked dataset
1 - 6 of 6
- Additional file 1: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 4: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 3: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 11: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)
- Additional file 9: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families (Creator)